Concepedia

Publication | Open Access

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

DOIFull Paper Access

29

Citations

14

References

2019

Year

Andrés F. Cardona, Alejandro Ruíz-Patiño, Zyanya Lucía Zatarain-Barrón, Fernando Hakim, Enrique Jiménez, Juan Armando Mejía, Juan Fernando Ramón, Nicolás Useche, Sonia Bermúdez, Diego Pineda,
PLoS ONE

Abstract

Sunitinib and octreotide/everolimus have similar efficacy and safety in the systemic management of refractory meningioma. VEGFR2 and PDGFRβ expression are associated with better outcomes.

References

YearCitations

Page 1